Western blotting confirmed the downregulation of fibrosis-related proteins such as TGFβ, α-SMA, and Col1a1, further supporting the therapeutic effects of BBR on renal fibrosis (Figures 8F,G). This evidence concerns the gene ACTA1 and renal fibrosis.